Deletion of the major proteolytic site of the Helicobacter pylori cytotoxin does not influence toxin activity but favors assembly of the toxin into hexameric structures

Infection and Immunity

Volumn 66, Issue 11, 1998, Pages 5547-5550

  Burroni, Daniela ^a   Lupetti, Pietro ^b   Pagliaccia, Cristina ^a   Reyrat, Jean Marc ^a   Dallai, Romano ^b   Rappuoli, Rino ^a   Telford, John L ^a  

^a CHIRON VACCINES   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; BACTERIAL TOXIN; DIPHTHERIA TOXIN; KANAMYCIN;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HYDROPHILICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TARGET CELL; TOXIN ANALYSIS;

EID: 0032444197     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.11.5547-5550.1998     Document Type: Article

References (14)

1. Cover, T. L., P. I. Hanson, and J. E. Heuser. 1997. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J. Cell Biol. 138:759-769.
2. de Bernard, M., E. Papini, V. de Filippis, E. Gottardi, J. L. Telford, R. Manetti, A. Fontana, R. Rappuoli, and C. Montecucco. 1995. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J. Biol. Chem. 270:23937-23940.
3. Giannelli, V., M. R. Fontana, M. M. Giuliani, D. Guangcai, R. Rappuoli, and M. Pizza. 1997. Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop. Infect. Immun. 65:331-334.
4. Labigne-Roussel, A., P. Courcoux, and L. Tompkins. 1988. Gene disruption and replacement as a feasible approach for mutagenesis of Campylobacter jejuni. J. Bacteriol. 170:1704-1708.
5. Lanzavecchia, S., P. Lupetti, P. L. Bellon, R. Dallai, R. Rappuoli, and J. L. Telford. 1998. Three dimensional reconstruction of metal replicas of the Helicobacter pylori vacuolating cytotoxin. J. Struct. Biol. 121:9-18.
6. Leunk, R. D., P. T. Johnson, B. C. David, W. G. Kraft, and D. R. Morgan. 1988. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 26:93-99.
7. Lupetti, P., J. E. Heuser, R. Manetti, P. Massari, S. Lanzavecchia, P. L. Bellon, R. Dallai, R. Rappuoli, and J. L. Telford. 1996. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J. Cell Biol. 133:801-507.
8. Manetti, R., P. Massari, D. Burroni, M. de Bernard, A. Marchini, R. Olivieri, E. Papini, C. Montecucco, R. Rappuoli, and J. L. Telford. 1995. Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies. Infect. Immun. 63:4476-4480.
9. Montecucco, C., E. Papini, and G. Schiavo. 1991. Molecular models of toxin membrane translocation, p. 45-56. In J. E. Alouf and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press, Inc., New York, N.Y.
10. Papini, E., M. Bugnoli, M. de Bernard, N. Figura, R. Rappuoli, and C. Montecucco. 1993. Bafylomicin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol. Microbiol. 7:323-327.
11. Reyrat, J. M., M. Charrel, C. Pagliaccia, D. Burroni, P. Lupetti, M. de Bernard, X. Ji, N. Norais, E. Papini, R. Dallai, R. Rappuoli, and J. L. Telford. 1998. Characterisation of a monoclonal antibody and its use to purify the cytotoxin of Helicobacter pylori. FEMS Microbiol. Lett. 165:79-84.
12. Telford, J. L., P. Ghiara, M. dell'Orco, M. Comanducci, D. Burroni, M. Bugnoli, M. F. Tecce, S. Censini, A. Covacci, Z. Xiang, E. Papini, C. Montecucco, L. Parente, and R. Rappuoli. 1994. Gene structure of Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179:1653-1658.
13. Wang, Y., and D. E. Taylor. 1990. Chloramphenicol resistance in Campy-lobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene 94:23-28.
14. Wang, Y., K. P. Roos, and D. E. Taylor. 1993. Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J. Gen. Microbiol. 139:2485-2493.